The role of interleukin-10 (IL-10) in IL-15-mediated T-cell responses

Blood

Volumn 90, Issue 11, 1997, Pages 4513-4521

  Körholz, Dieter ^a   Banning, Ursula ^b   Bönig, Halvard ^b   Grewe, Markus ^b   Schneider, Marion ^b   Mauz Körholz, Christine ^b   Klein Vehne, Anne ^b   Krutmann, Jean ^b   Burdach, Stephan ^b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ARTICLE; CELL PROLIFERATION; CYTOTOXICITY; DOSE RESPONSE; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOTHERAPY; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION;

EID: 0344815417     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.11.4513.4513_4513_4521     Document Type: Article

References (43)

1. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, Giri JG: Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264:965, 1994
2. Giri JG, Anderson DM, Kumaki S, Park LS, Grabstein KH, Cosman D: Interleukin 15, a novel T-cell growth factor that shares activities and receptor components with IL 2. J Leukoc Biol 57:763, 1995
3. Matthews DJ, Clark PA, Herbert J, Morgan G, Armitage RJ, Kinnon C, Minty A, Grabstein KH, Caput D, Ferrara P, Callard R: Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15. Blood 85:38, 1995
4. Kumaki S, Ochs HD, Timour M, Schooley K, Ahdieh M, Hill H, Sugamura K, Anderson D, Zhu Q, Cosman D, Giri JG: Characterization of B cell lines established from two X-linked severe combined immunodeficiency patients: interleukin 15 binds to the B cells but is not internalized efficiently. Blood 86: 1428, 1995
5. Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, Ortaldo JR, Gupta S, Chen YQ, Giri JD, O'Shea JJ: Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukin 2 and 15. Proc Natl Acad Sci USA 92:8705, 1995
6. Lin JX, Migone TS, Tsang M, Friedmann M, Weatherbee JA, Zhou L, Yamauchi A, Bloom ET, Mietz J, John S: The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331, 1995
7. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D: Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13: 2822, 1994
8. Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA: IL-15: A pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4:329, 1996
9. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH: IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 154:483, 1995
10. Seder RA, Grabstein KH, Berzofsky JA, McDyer JF: Cytokine interactions in human immunodeficiency virus-infected individuals: Roles of interleukin(IL)-2, IL-12 and IL-15. J Exp Med 182:1067, 1995
11. Giri JG, Kumaki S, Ahdieh M, Friend DJ, Loomis A, Shanebeck K, DuBose R, Cosman D, Park LS, Anderson DM: Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J 14:3654, 1995
12. Rosenberg SA, Lotze MT: Cancer immunotherapy using interleukin 2 and interleukin 2 activated lymphocytes. Annu Rev Immunol 4:681, 1986
13. Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA, Simpson C, Reichert CM: Oberservations on the systemic administration of autologous lymphokine activated killer cells and recombinant interleukin 2 to patients with metastatic cancer. N Engl J Med 313:1485, 1985
14. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT: A progress report on the treatment of 157 patients with advanced cancer using lymphokine activated killer cells and interleukin 2 or high dose interleukin 2 alone. N Engl J Med 316:889, 1987
15. Dilloo D, Laws HJ, Hanenberg H, Körholz D, Nürnberger W, Burdach S: Induction of two distinct natural killer cell populations, activated T-cells and antineoplastic cytokines by interleukin-2 therapy in children with solid tumors. Exp Hematol 22:1081, 1994
16. Munger W, DeJoy SQ, Jeyaseelan R Sr, Torley LW, Grabstein KH, Eisenmann J, Paxton R, Cox T, Wick MM, Kerwar SS: Studies evaluating the antitumor activity and toxicity of interleukin 15, a new T cell growth factor: Comparison with interleukin 2. Cell Immunol 165:289, 1995
17. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin 10 (IL-IO) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041, 1993
18. De Waal Malefyt R, Yssel H, De Vries JE: Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 150:4754, 1993
19. Hempel L, Körholz D, Bönig H, Burdach S: Interleukin-10 directly inhibited the production of Interleukin-6 in human T cells. Scand J Immunol 41:462, 1995
20. Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K, Caligiuri MA: Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J Clin Invest 96:2578, 1995
21. Flamand L, Stefanescu I, Menezes J: Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J Clin Invest 97:1373, 1996
22. Doherty TM, Seder RA, Sher A: Induction and regulation of IL-15 expression in murine macrophages. J Immunol 156:735, 1996
23. Taga K, Mostowski H, Tosato G: Human interleukin-10 can directly inhibit T-cell growth. Blood 81:2964, 1993
24. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
25. Chen YH, Desai P. Shiao RT, Lavelle D, Hateem A, Chen J: Inhibition of myeloma cell growth by dexamethasone and alltrans retinoic acid: Synergy through modulation of interleukin 6 autocrine loop at multiple sites. Blood 87: 314, 1996
26. Ballagi-Pordany A, Ballagi-Pordany A, Funa K: Quantitative determination of mRNA phenotypes by the polymerase chain reaction. Anal Biochem 196:89, 1991
27. Bonig H, Körholz D, Pafferath B, Mauz-Körholz C, Burdach S: Interleukin 10 induces c-fos expression in human B-cells by activation of divergent protein kinases. Immunol Invest 25:115, 1996
28. Gray PW, Leung DW, Pennica D, Yelverton E, Najarian R, Simonsen CC, Derynck R, Sherwood PJ, Wallace DM, Berger SL, Levinson-AD, Goeddel-DV: Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 295:503, 1982
29. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA: Interleukin (IL)-15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180:1395, 1994
30. Taga K, Tosato G: IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 148:1143, 1992
31. Ling P, Gately MK, Gubler U, Stern AS, Lin P, Hollfelder K, Su C, Pan YC, Hakimi J: Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 154:116, 1995
32. Kanegane H, Tosato G: Activation of naive and memory T cells by interleukin-15. Blood 88:230, 1996
33. Meyaard L, Hovenkamp E, Otto SA, Miedema F: IL-12 induced IL-10 production by human T cells as a negative feedback for IL-12 induced immune responses. J Immunol 156:2776, 1996
34. c subunits. J Immunol 156:1339, 1996
35. Kumaki S, Armitage R, Ahdieh M, Park L, Cosman D: Interleukin-15 up-regulates interleukin-2 receptor a chain but down-regulates its own high-affinity binding sites on human T and B cells. Eur J Immunol 26:1235, 1996
36. Mori A, Suko M, Kaminuma O, Inoue S, Ohmura T, Nishizaki Y, Nagahori T, Asakura Y, Hoshino A, Okumura Y, Saro G, Ito K, Okudaira H: IL-15 promotes cytokine production of human T helper cells. J Immunol 156:2400, 1996
37. Kennedy MK, Picha KS, Shanebeck KD, Anderson DM, Grabstein KH: Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones. Eur J Immunol 24:2271, 1994
38. Jeannin P, Delneste Y, Seveso M, Life P, Bonnefoy JY: IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells. J Immunol 156:3159, 1996
39. Armant M, Armitage R, Boiani N, Delespesse G, Sarfati M: Functional CD40 ligand expression on T lymphocytes in the absence of T cell receptor engagement: involvement in interleukin-2-induced interleukin-12 and interferon-g production. Eur J Immunol 26:1430, 1996
40. McHugh S, Deighton J, Rifkin I, Ewan P: Kinetics and functional implications of Th-1 and Th-2 cytokine production following activation of peripheral blood mononuclear cells in primary culture. Eur J Immunol 26: 1260, 1996
41. Carson WE, Lindemann MJ, Baiocchi R, Linett M, Tan JC, Chou CC, Narula S, Caligiuri MA: The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood 85:3577, 1995
42. Gamero AM, Ussery D, Reintgen DS, Puleo CA, Djeu JY: Interleukin 15 induction of lymphokine activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18 dependent, perforin-related mechanism. Cancer Res 55:4988, 1995
43. Porgador A, Bannerji R, Watanabe Y, Feldman M, Gilboa E, Eisenbach L: Antimetastatic vaccination of tumor bearing mice with two types of IFN-gamma gene inserted tumor cells. J Immunol 150:1458, 1993